SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

Round up of drug delivery news

07-Jun-2012 - in-PharmaTechnologist.com presents a roundup of drug delivery news, including a FDA set back at Amylin and expansion at Particle Sciences.

Aptar to enter injectable device components with €165m buy

04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.

West eyes growth from FDA biosimilar delivery flexibility

28-May-2012 - West Pharmaceutical Services expects significant growth from biosimilars as manufacturers use novel delivery devices as a “key differentiator”.

Generic Lipitor drives jump in pharma revenues at Codexis

15-May-2012 - Codexis posted a jump in pharma sales after the Lipitor patent loss drove an uptick in demand for its atorvastatin intermediate.

Generics rise sparks delivery tech need; Interphex speaker

07-May-2012 - The need for novel delivery technologies is greater than ever as firms scramble to extract maximum value from drugs, an Interphex speaker said.

Selecting formulation early cuts time to market, says Formac

21-Mar-2012 - Formac Pharmaceuticals and WR Grace say their silica platform can improve the formulation selection process for poorly soluble APIs (active pharmaceutical ingredients).

Acuros in talks with Big Pharma over water-powered delivery pump

13-Mar-2012 - Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.

FDA biosimilar guidance permits alternative drug delivery devices

13-Feb-2012 - The FDA has said biosimilars can use different drug delivery devices than their reference products in its long-awaited guidance.

Samsung and Quintiles' biosimilars JV teams with Biogen Idec

06-Dec-2011 - Samsung will set up a $300m biosimilars development JV with Massachusetts, US-based Biogen Idec, building on the partnership it forged with CRO Quintiles earlier this year.

Ongoing quality problems at injectables plant hurt Hospira in Q3

19-Oct-2011 - Hospira says ‘quality actions’ taken to fix problems at key injectable drug manufacturing plant in US reduced its third quarter earnings.

Rituximab success paves way for plant produced mAbs

10-Oct-2011 - iBio is expanding use of its green plant technology to biosimilar mAbs after producing rituximab using the system.

News in brief

Dong-A and Meiji Seika to build biosimilars plant

06-Oct-2011 - South Korean drugmaker Dong-A and Japan’s Meiji Seika Pharma will build a biosimilars plant in a bid to target the global Ab-based drug market.

ProMetic supplying adsorbent to Chinese biosimilar biz

26-Sep-2011 - ProMetic Life Sciences is supplying an affinity adsorbent to a Chinese biopharm for use in scale-up of a biosimilar.

UK drug re-developer sees business in pharma turmoil

22-Sep-2011 - Oxford Pharmascience expects the challenges facing biopharm to drive interest in its drug delivery and reformulation technologies.

Albemarle to hike generic API prices on regulatory costs

14-Sep-2011 - Albemarle says it will increase what it charges for generic APIs from next month, citing increasing regulatory and testing costs as the main reasons for the hike.

Biocon building Malaysia plant to serve Pfizer insulin deal

14-Sep-2011 - Biocon has begun work on the Malaysian biopharm plant that will serve its deal with Pfizer, and is now providing Lipitor ingredients.

update

Granules to expand API and intermediate capacity

29-Aug-2011 - Chemicals maker Granules India says it will expand manufacturing capacity for oral solid dose (OSD) APIs and drug intermediates in a bid to better meet the needs of clients.

Specialty generic players a target for OctoPlus tech

02-Aug-2011 - OctoPlus is targeting specialty generics manufacturers it believes can benefit from its controlled release drug delivery technologies.

Market share gains drive MWV medical pump growth

28-Jul-2011 - MeadWestvaco (MWV) has reported increased market share is driving double-digit growth in sales of medical pumps.

Europe approves Merck Serono prefilled pen injectors

05-Jul-2011 - Merck Serono has received European approval for prefilled pen injectors designed to increase compliance during fertility treatment.

News in brief

Par to reduce sales headcount at Strativa unit

30-Jun-2011 - Par Pharmaceutical will cut 100 jobs at its proprietary products division Strativa Pharmaceuticals as part of a restructuring plan designed to save as much as $12m.

PhRMA and GPhA disagree on ‘first to file’ US patent law plan

27-Jun-2011 - The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.

Hovione and PSI team on poorly soluble APIs

09-Jun-2011 - Portugal-headquartered API manufacturer Hovione has teamed up with Particle Sciences (PSI) to tackle the issue of poor drug solubility.

Functional excipients to drive US market to $2bn by 2015, study

08-Jun-2011 - Demand for functional excipients will drive growth of the US market over the next few years according to new analysis.

Pfizer considers generics manufacturing JV with Hisun

06-Jun-2011 - Pfizer says it is considering a manufacturing-focused partnership with China’s Zhejiang Hisun Pharmaceutical as part of its generic drug business.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...